2,388 Shares in DexCom, Inc (NASDAQ:DXCM) Bought by Moody Aldrich Partners LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Oppenheimer & Co. Inc. lowered its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,218 shares of the medical device company’s stock after selling 518 shares during the period. […]
Trinity Biotech plc. paid $12.5 million to acquire Waveform Technologies Inc.’s biosensor and continuous glucose monitoring (CGM) assets. It also formed a partnership with Bayer AG to launch a CGM biosensor in China and India. These moves are part of Trinity’s transformation strategy to become a leading player in wearable biosensor technology.